Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hypoxic Tumours × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2619 Neoplasms 2349 Lung Neoplasms 1207 Colorectal Neoplasms 1179 Prostatic Neoplasms 1098 Carcinoma, Non-Small-Cell Lung 961 Carcinoma, Hepatocellular 691 Stomach Neoplasms 633 Pancreatic Neoplasms 611 Ovarian Neoplasms 523 Colonic Neoplasms 470 Head and Neck Neoplasms 441 Uterine Cervical Neoplasms 434 Rectal Neoplasms 421 Melanoma 417 Multiple Myeloma 416 Esophageal Neoplasms 382 Neoplasm Metastasis 376 Brain Neoplasms 365 Lymphoma 349 Precursor Cell Lymphoblastic Leukemia-Lymphoma 346 Urinary Bladder Neoplasms 342 Leukemia, Myeloid, Acute 332 Carcinoma, Renal Cell 303 Leukemia 298 Liver Neoplasms 281 Hematologic Neoplasms 278 Endometrial Neoplasms 276 Recurrence 257 Glioma 236

Interventions

fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00756691 2017-11-14

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

AHS Cancer Control Alberta

Hypoxic Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡